There’s no doubt HCQ inhibits the virus through multiple pathways

Sharing is Caring!

by Jim

Here is how Dr. Shiva A., MIT Biological Engineering PhD and developer of CytoSolve depicted it in early May;

We knew from the earliest in-vitro studies of infected cells that HCQ (along with Remdesivir) inhibited viral replication.. what was really cool I thought was the later data that came out showing that there was also dose-dependent inhibition of cellular entry via ACE2, which of course is a completely separate and complimentary mode of action.  HCQ is in a sense a single molecule, “cocktail”.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.